Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Blood

• Publication date

  2018-03-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2017-12-820852PMID 29326099PMCID PMC5877443
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erythematous nodes, urticarial rash and arthralgias in a large pedigree with NLRC4‐related autoinflammatory disease, expansion of the phenotype

  2017cited by this paper
• Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition.

  2017cited by this paper
• Inflammatory Gene Expression Profile and Defective Interferon‐γ and Granzyme K in Natural Killer Cells From Systemic Juvenile Idiopathic Arthritis Patients

  2017cited by this paper
• Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis

  2017cited by this paper
• Novel NLRC4 Mutation Causes a Syndrome of Perinatal Autoinflammation With Hemophagocytic Lymphohistiocytosis, Hepatosplenomegaly, Fetal Thrombotic Vasculopathy, and Congenital Anemia and Ascites

  2017cited by this paper
• NAIP‐NLRC4 Inflammasomes Coordinate Intestinal Epithelial Cell Expulsion with Eicosanoid and IL‐18 Release via Activation of Caspase‐1 and ‐8

  2017cited by this paper
• Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications

  2016cited by this paper
• Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza.

  2016cited by this paper
• 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

  2016cited by this paper
• Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial*

  2016cited by this paper
• Elevated serum levels of free interleukin-18 in adult-onset Still's disease.

  2016cited by this paper
• NLRP3 recruitment by NLRC4 during Salmonella infection

  2016cited by this paper
• Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

  2016cited by this paper
• GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo.

  2016cited by this paper
• A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice.

  2015cited by this paper
• Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.

  2015cited by this paper
• Natural killer cells: In health and disease.

  2015cited by this paper
• Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis.

  2015cited by this paper
• Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling.

  2015cited by this paper
• Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis.

  2015cited by this paper
• Inflammasome activation causes dual recruitment of NLRC4 and NLRP3 to the same macromolecular complex

  2014cited by this paper
• Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients

  2014cited by this paper
• Interferon-γ Induces Expression of MHC Class II on Intestinal Epithelial Cells and Protects Mice from Colitis

  2014cited by this paper
• An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome

  2014cited by this paper
• An inherited mutation in NLRC4 causes autoinflammation in human and mice

  2014cited by this paper
• Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation

  2014cited by this paper
• Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis

  2014cited by this paper
• Whole‐Exome Sequencing Reveals Overlap Between Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis and Familial Hemophagocytic Lymphohistiocytosis

  2014cited by this paper
• Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.

  2013cited by this paper
• Innate lymphoid cells regulate CD4+ T cell responses to intestinal commensal bacteria

  2013cited by this paper
• Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis.

  2013cited by this paper
• Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes.

  2013cited by this paper
• Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies.

  2013cited by this paper
• Interleukin-18, more than a Th1 cytokine.

  2013cited by this paper
• Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells.

  2013cited by this paper
• Treatment of Epstein Barr virus‐induced haemophagocytic lymphohistiocytosis with rituximab‐containing chemo‐immunotherapeutic regimens

  2013cited by this paper
• Lethal inflammasome activation by a multi-drug resistant pathobiont upon antibiotic disruption of the microbiota

  2012cited by this paper
• Effect of anticoagulants on multiplexed measurement of cytokine/chemokines in healthy subjects.

  2012cited by this paper
• Amplification of the response to Toll-like receptor ligands by prolonged exposure to interleukin-6 in mice: implication for the pathogenesis of macrophage activation syndrome.

  2012cited by this paper
• Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.

  2012cited by this paper
• Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.

  2011cited by this paper
• Perforin is a critical physiologic regulator of T-cell activation.

  2011cited by this paper
• Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice.

  2011cited by this paper
• Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice.

  2011cited by this paper
• Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery

  2010cited by this paper
• The Gene Expression Barcode: leveraging public data repositories to begin cataloging the human and murine transcriptomes

  2010cited by this paper
• Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis.

  2010cited by this paper
• Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity.

  2009cited by this paper
• Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.

  2009cited by this paper
• Neutralization of IFNγ defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice

  2009cited by this paper
• Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis

  2008cited by this paper
• The Immunological Genome Project: networks of gene expression in immune cells

  2008cited by this paper
• HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis

  2007cited by this paper
• Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis

  2007cited by this paper
• Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France

  2007cited by this paper
• A multicenter study of patients with adult-onset Still’s disease compared with systemic juvenile idiopathic arthritis

  2006cited by this paper
• Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.

  2006cited by this paper
• Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome.

  2005cited by this paper
• An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.

  2004cited by this paper
• A gene atlas of the mouse and human protein-encoding transcriptomes.

  2004cited by this paper
• International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.

  2004cited by this paper
• Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome

  2004cited by this paper
• A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity

  2002cited by this paper
• Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation.

  2002cited by this paper
• A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18.

  2001cited by this paper
• Perforin gene defects in familial hemophagocytic lymphohistiocytosis.

  1999cited by this paper

• IL-18 and the Quest for the Holy Grail (in Still's Disease).

  2026cites this paper
• Transition of serum-free IL-18 levels in systemic juvenile idiopathic arthritis measured by a novel detection method.

  2026cites this paper
• The innate cytokine IL-18 inhibits CNS autoimmunity through preferential activation of protective CD8 T-cells

  2026influential citation
• IL-18 binding protein attenuates neuroinflammation and cognitive decline in Alzheimer's disease.

  2026cites this paper
• CAR T cell therapies in gastrointestinal cancers: current clinical trials and strategies to overcome challenges

  2025cites this paper
• Hemophagocytic lymphohistiocytosis: an update in diagnostics, criteria, and treatment considerations.

  2025cites this paper
• Development of anti-murine IL-18 binding protein antibodies to stimulate IL-18 bioactivity.

  2025cites this paper
• Neutrophilic Urticarial Dermatosis: A Window into Systemic Inflammation and Autoimmune Disorders

  2025cites this paper
• IL-1 family cytokines in inflammation and immunity

  2025cites this paper
• Modeling the HLH immune synapse uncovers critical roles for IS termination, cytokine intensity, and target cell death.

  2025cites this paper
• Elevated serum levels of interleukin-18 discriminate Still’s disease from other autoinflammatory conditions: results from the European ImmunAID cohort

  2025cites this paper
• Assessment of Hemophagocytic Lympho‐Histiocytosis (HLH) in the Setting of Adult Acute Liver Failure

  2025cites this paper
• Baseline Clinical Features and Biomarker Profiles of the Childhood Arthritis and Rheumatology Research Alliance Systemic Juvenile Idiopathic Arthritis- Associated Lung Disease Cohort.

  2025cites this paper
• An animal model of NLRC4-associated autoinflammation and infantile enterocolitis reveals novel therapeutic strategies

  2025cites this paper
• A germline IκBα mutation outside the signal reception domain blocks nuclear translocation of NFκB1 and associates with autoinflammation-like features.

  2025cites this paper
• Makrophagenaktivierungssyndrom: Notfall mit therapeutischen Herausforderungen

  2025cites this paper
• Diagnostic testing for hemophagocytic lymphohistiocytosis.

  2025cites this paper
• Monocyte/macrophages may exert prominent roles in macrophage activation syndrome

  2025cites this paper
• Multimodal induction of fulminant HLH by IL-18 includes virus-specific NK immunodeficiency

  2025cites this paper
• Unmet needs and research gaps in Still’s disease across ages: proceedings from a pediatric and adult joint expert panel

  2025cites this paper
• Histiocyte Society blueprint for hemophagocytic lymphohistiocytosis research: deciphering underlying disease mechanisms to optimize diagnosis and therapy

  2025influential citation
• T-ing up the storm: pathogenic cycling lymphocytes in the biology of macrophage activation syndrome

  2025cites this paper
• Hemophagocytic lymphohistiocytosis and other histiocytic disorders of the bone marrow in children

  2025cites this paper
• Macrophage Activation Syndrome: Not Just for Rheumatologists Anymore.

  2025cites this paper
• Biomarkers of Immune Dysregulation and What They Tell Us: Gene Sequencing Is Not the Answer to Every Question.

  2025cites this paper
• Free Interleukin 18 (IL-18F) Blood Levels Following Midline Laparotomy: A Prospective Randomized Study of Patients With Benign Disease and Patients With Cancer

  2025cites this paper
• Risk and response adapted treatment in pediatric Epstein-Barr virus associated hemophagocytic lymphohistiocytosis.

  2025cites this paper
• Inflammasomopathies: mechanisms and disease signatures.

  2025cites this paper
• Weal and woe of interleukin-18 in the T cell therapy of cancer

  2025cites this paper
• Epstein-Barr Virus Seropositivity, Immune Dysregulation, and Mortality in Pediatric Sepsis

  2025cites this paper
• Case Report: A role for hemoadsorption in hemophagocytic lymphohistiocytosis

  2025cites this paper
• The IL-18 receptor is expressed on murine small-intestinal enterochromaffin cells and executes a recovery program upon injury

  2025cites this paper
• Etiologies and long-term outcome of pediatric hemophagocytic lymphohistiocytosis and macrophage activation syndrome in Taiwan: a single-center retrospective study

  2025cites this paper
• Chimeric antigen receptor T cell immunotherapy-associated hemophagocytic lymphohistiocytosis: Pathogenesis, clinical manifestation, diagnosis and management compared with cytokine release syndrome (Review)

  2025cites this paper
• Hyperferritinemia Screening to Aid Identification and Differentiation of Patients with Hyperinflammatory Disorders

  2024influential citation
• Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis.

  2024cites this paper
• Potential therapeutic and ameliorative effects of ramipril alone and in combination with methylprednisolone for the cytokine releasing syndrome in mice: An in vivo study

  2024cites this paper
• DOCK8 at the crossroads of immunodeficiency and hyperinflammation.

  2024cites this paper
• IL-18 and IL-18BP: A Unique Dyad in Health and Disease

  2024cites this paper
• IL-1 Family Blockade in Cytokine Storm Syndromes.

  2024cites this paper
• The NLRP3 inflammasome is essential for IL-18 production in a murine model of macrophage activation syndrome

  2024influential citation
• Features of hyperinflammation link the biology of EBV infection and cytokine storm syndromes.

  2024cites this paper
• Hemophagocytic lymphohistiocytosis post chimeric antigen receptor T cell therapies

  2024cites this paper
• Avoiding Rash Decisions.

  2024cites this paper
• Macrophage Activation Syndrome

  2024cites this paper
• NLRC4-associated autoinflammatory disease: insights from mouse models and somatic variants.

  2024cites this paper
• New insights into CAR T-cell hematological toxicities: manifestations, mechanisms, and effective management strategies

  2024cites this paper
• Non-Skewed X-inactivation Results in NF-κB Essential Modulator (NEMO) Δ-exon 5-autoinflammatory Syndrome (NEMO-NDAS) in a Female with Incontinentia Pigmenti

  2024cites this paper
• Serum Cytokine Panels in Pediatric Clinical Practice.

  2024cites this paper
• Pathogenic diversification of the gut commensal Providencia alcalifaciens via acquisition of a second type III secretion system

  2024cites this paper
• Anti-Interferon-γ Therapy for Cytokine Storm Syndromes.

  2024cites this paper
• Biomarkers in Pediatric Hemophagocytic Lymphohistiocytosis With Central Nervous System Involvement: A Cohort Study

  2024cites this paper
• Systemic juvenile idiopathic arthritis and adult-onset Still’s disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still’s disease

  2024influential citation
• [Autoinflammatory diseases associated with IL-18].

  2024cites this paper
• Kawasaki Disease-Associated Cytokine Storm Syndrome.

  2024cites this paper
• Other Immunomodulatory Treatment for Cytokine Storm Syndromes.

  2024cites this paper
• Genetics of Primary Hemophagocytic Lymphohistiocytosis.

  2024cites this paper
• Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project

  2024cites this paper
• Hyperferritinemia screening to aid identification and differentiation of patients with hyperinflammatory disorders

  2024influential citation
• Serum interleukin-18 levels can improve the diagnostic performance of the PRINTO and ILAR criteria for systemic juvenile idiopathic arthritis.

  2024cites this paper
• Murine Models of Secondary Cytokine Storm Syndromes.

  2024cites this paper
• The NLRP3 inflammasome is essential for IL-18 production in a murine model of macrophage activation syndrome

  2024cites this paper
• Interleukin‑18 binding protein: Biological properties and roles in human and animal immune regulation (Review)

  2024cites this paper
• Dietary fiber guar gum-induced shift in gut microbiota metabolism and intestinal immune activity enhances susceptibility to colonic inflammation

  2024cites this paper
• Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases

  2024cites this paper
• Diagnostic Challenges in Hemophagocytic Lymphohistiocytosis, a Rare, Potentially Fatal Disease: Two Case Studies

  2024cites this paper
• Identification of miRNAs that target Fcγ receptor-mediated phagocytosis during macrophage activation syndrome

  2024cites this paper
• Editorial: Towards a better understanding of hemophagocytic lymphohistiocytosis

  2024cites this paper
• New discoveries in the genetics and genomics of systemic juvenile idiopathic arthritis

  2024cites this paper
• Heterogeneity of macrophage activation syndrome and treatment progression

  2024cites this paper
• A MASsive attack: a pediatric case of macrophage activation syndrome complicated by DIC as an onset of systemic juvenile idiopathic arthritis successfully treated with anakinra and review of the literature

  2024cites this paper
• An antibody to IL-1 receptor 7 protects mice from LPS-induced tissue and systemic inflammation

  2024cites this paper
• CRP and sCD25 help distinguish between adult‐onset Still's disease and HLH

  2024cites this paper
• NLRP1B expressed in intestinal epithelial cells is refractory to activation with Val-boro-Pro.

  2024cites this paper
• Current and emerging pharmacotherapies for cytokine release syndrome, neurotoxicity, and hemophagocytic lymphohistiocytosis-like syndrome due to CAR T cell therapy

  2024cites this paper
• Autoinflammatory Contributors to Cytokine Storm.

  2024cites this paper
• Immunopathology of and potential therapeutics for secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome: a translational perspective

  2024cites this paper
• Acute kidney injury in critical care: complications of hemophagocytic lymphohistiocytosis

  2024cites this paper
• CD8+ T Cell Biology in Cytokine Storm Syndromes.

  2024cites this paper
• Inflamed-HLH, MAS, or something else?

  2023cites this paper
• Inpatient recognition and management of HLH.

  2023cites this paper
• Biological and clinical roles of IL-18 in inflammatory diseases

  2023influential citation
• Type 1 Interferon‐Stimulated Gene Expression and Disease Activity in Pediatric Rheumatic Diseases: No Composite Scores Needed?

  2023cites this paper
• Diagnosis and Management of the Systemic Juvenile Idiopathic Arthritis Patient with Emerging Lung Disease

  2023cites this paper
• The autoinflammation-associated NLRC4V341A mutation increases microbiota-independent IL-18 production but does not recapitulate human autoinflammatory symptoms in mice

  2023cites this paper
• The 4th NextGen therapies of SJIA and MAS, part 4: it is time for IL-18 based trials in systemic juvenile idiopathic arthritis?

  2023cites this paper
• Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion

  2023cites this paper
• Development of a Screening Algorithm for Lung Disease in Systemic Juvenile Idiopathic Arthritis

  2023cites this paper
• Complementary HLH susceptibility factors converge on CD8 T-cell hyperactivation

  2023cites this paper
• Early B cell development and B cell maturation are impaired in patients with active hemophagocytic lymphohistiocytosis.

  2023cites this paper
• NLRC4 gain-of-function variant is identified in a patient with systemic lupus erythematosus.

  2023cites this paper
• Hyperferritinemic sepsis, macrophage activation syndrome, and mortality in a pediatric research network: a causal inference analysis

  2023cites this paper
• Type I interferon signature and cycling lymphocytes in macrophage activation syndrome

  2023cites this paper
• The 4th NextGen Therapies for SJIA and MAS: part 1 the elephant in the room: diagnostic/classification criteria for systemic juvenile idiopathic arthritis and adult-onset still’s disease

  2023cites this paper
• Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis.

  2023cites this paper
• Approach to Diagnosing Inborn Errors of Immunity.

  2023cites this paper
• Hemophagocytic Lymphohistiocytosis With Elevated Cytokines Related to Macrophage Activation After Liver Transplantation for Autoimmune Hepatitis: A Case Report.

  2023cites this paper
• Free interleukin-18 is elevated in CD22 CAR T-cell–associated hemophagocytic lymphohistiocytosis–like toxicities

  2023cites this paper
• Distinct roles of IL-18 and IL-1β in murine model of macrophage activation syndrome.

  2023cites this paper
• Interferons as key factors for pathogenesis, diagnostics and treatment

  2023cites this paper